Organigram Global Inc. (OGI)
(Delayed Data from NSDQ)
$1.33 USD
-0.01 (-0.75%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $1.34 +0.01 (0.75%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth A Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
OGI 1.33 -0.01(-0.75%)
Will OGI be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for OGI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for OGI
Beat the Market the Zacks Way: Curtiss-Wright, Oracle, Starbucks in Focus
OrganiGram (OGI) Reports Q2 Loss, Beats Revenue Estimates (Revised)
OGI: What are Zacks experts saying now?
Zacks Private Portfolio Services
OrganiGram (OGI) Reports Q2 Loss, Misses Revenue Estimates
InfuSystems Holdings, Inc. (INFU) Reports Q1 Loss, Tops Revenue Estimates
Bio-Rad Laboratories (BIO) Q1 Earnings Surpass Estimates
Other News for OGI
Organigram to Report Third Quarter Fiscal 2025 Results on August 13, 2025 | OGI Stock News
Tilray sends pot stocks lower after Q4 results
Village Farms: Why It Is Time To Move To The Sidelines
U.S. Senate confirms President Trump’s DEA pick
Marijuana rescheduling process remains stalled, DEA says